Internal Medicine, Pulmonary Disease · Washington, MO
NPI
1245251321
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
901 Patients First Dr
Washington, MO, 63090
Phone (636) 231-6245
Groups this clinician bills Medicare through
Medicare paid, 2024
$96K
1,663 services
Medicare patients, 2024
581
Average age 73
Drug cost, 2024
$2.6M
7,771 prescriptions
Company payments, 2025
$8,895
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Umer H Siddiqui was code 99214 (office e&m - established), 625 times for 328 patients. In total Umer H Siddiqui billed 1,663 services in 26 codes, and Medicare paid $96K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 625 | 328 | $83.03 | $52K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 180 | 177 | $12.21 | $2,198 |
| 99213 Office E&M - Established | Office | 155 | 134 | $59.65 | $9,246 |
| 94729 Pulmonary Function Testing | Facility | 91 | 91 | $6.28 | $572 |
| 94726 Pulmonary Function Testing | Facility | 90 | 90 | $8.46 | $762 |
| 99204 Office E&M - New | Office | 81 | 81 | $97.35 | $7,886 |
| 99233 Hospital E&M - Subsequent | Facility | 75 | 39 | $86.40 | $6,480 |
| 99223 Hospital E&M - Initial | Facility | 57 | 53 | $126.86 | $7,231 |
| 94010 Pulmonary Function Testing | Facility | 49 | 49 | $5.59 | $274 |
| 94618 Pulmonary Function Testing | Facility | 49 | 49 | $16.13 | $791 |
| 94060 Pulmonary Function Testing | Facility | 43 | 43 | $7.54 | $324 |
| 95806 Sleep Study | Office | 42 | 42 | $29.40 | $1,235 |
| 99232 Hospital E&M - Subsequent | Facility | 20 | 17 | $58.42 | $1,168 |
| 94618 Pulmonary Function Testing | Office | 13 | 13 | $18.97 | $247 |
| 95811 Sleep Study | Office | 12 | 11 | $120.53 | $1,446 |
By year: 2022 $123K for 1,866 services; 2023 $108K for 1,578 services; 2024 $96K for 1,663 services.
Medicare prescription drug claims, 2024
In 2024, the drug Umer H Siddiqui prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,392 prescriptions and refills. In total Umer H Siddiqui wrote 7,771 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,392 | 1,798 | 261 | $1.2M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,089 | 1,320 | 313 | $27K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 553 | 679 | 113 | $431K |
| Prednisone Generic | 546 | 554 | 232 | $1,280 |
| Azithromycin Generic | 415 | 544 | 106 | $4,098 |
| Montelukast Sodium Generic | 390 | 768 | 87 | $2,490 |
| Roflumilast Generic | 351 | 484 | 73 | $28K |
| Doxycycline Hyclate Generic | 327 | 327 | 194 | $3,003 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 209 | 249 | 51 | $20K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 197 | 211 | 37 | $95K |
| Breo Ellipta Fluticasone/Vilanterol | 186 | 220 | 36 | $88K |
| Spiriva Respimat Tiotropium Bromide | 167 | 209 | 48 | $109K |
| Symbicort Budesonide/Formoterol Fumarate | 157 | 209 | 41 | $46K |
| Pantoprazole Sodium Generic | 146 | 266 | 36 | $1,157 |
| Ventolin Hfa Albuterol Sulfate | 137 | 151 | 37 | $8,810 |
Brand drugs: 4,064 claims; generic drugs: 3,707 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Umer H Siddiqui $8,895 ($8,895 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $8,074.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 22 | $8,074 |
| GlaxoSmithKline, LLC. GSK | 20 | $398 |
| Amgen Inc. AMGN | 3 | $52.45 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $50.46 |
| Harmony Biosciences LLC HRMY | 2 | $45.52 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $36.1 |
| Genzyme Corporation SNY | 2 | $32.32 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $29.48 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $26 |
| Lilly USA, LLC LLY | 1 | $24.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.